Government Resource Abbott Diabetes Care blood glucose meters. Save Save to your library Print Share Facebook Twitter Linkedin Copy URL November 9, 2005 This announcement alerts patients and practitioners to a problem with glucose meters made by Abbott Diabetes Care. The meters have a measurement setting that, if inadvertently switched, could cause an inaccurate reading. Save Save to your library Print Share Facebook Twitter Linkedin Copy URL Cite Related Resources Challenge Competition: Impact of Patient Safety Tools. December 12, 2023 Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. June 28, 2023 Examples of Medical Device Misconnections. March 8, 2023 Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022 Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication. May 4, 2022 NAM Scholars in Diagnostic Excellence program. January 31, 2022 Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021 Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples. October 7, 2021 Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021 Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. August 25, 2021 FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021 FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. February 17, 2021 Using ventilator splitters during the COVID-19 pandemic--letter to health care providers. February 17, 2021 Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021 Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. January 13, 2021 Wear face masks with no metal during MRI exams. December 16, 2020 Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020 FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020 FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. August 5, 2020 FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020 FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020 FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019 FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018 Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018 FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. June 20, 2018 FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018 Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions. January 25, 2017 Medical gas containers and closures; current good manufacturing practice requirements. November 18, 2016 Designing and Delivering Whole-Person Transitional Care: Hospital Guide to Reducing Medicaid Readmissions. September 3, 2016 View More See More About The Topic Physicians Nurses Health Care Executives and Administrators Medicine Medical Device Design
Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. June 28, 2023
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022
Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021
Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021
Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. August 25, 2021
FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021
FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022
Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. February 17, 2021
Using ventilator splitters during the COVID-19 pandemic--letter to health care providers. February 17, 2021
Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021
Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. January 13, 2021
Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020
FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020
FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. August 5, 2020
FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019
FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018
FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. June 20, 2018
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018
Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions. January 25, 2017
Medical gas containers and closures; current good manufacturing practice requirements. November 18, 2016
Designing and Delivering Whole-Person Transitional Care: Hospital Guide to Reducing Medicaid Readmissions. September 3, 2016